LV12211A - Homoeritromicina-a atvasinajumi - Google Patents

Homoeritromicina-a atvasinajumi

Info

Publication number
LV12211A
LV12211A LV980187A LV980187A LV12211A LV 12211 A LV12211 A LV 12211A LV 980187 A LV980187 A LV 980187A LV 980187 A LV980187 A LV 980187A LV 12211 A LV12211 A LV 12211A
Authority
LV
Latvia
Prior art keywords
hydrogen
hydroxyl
compounds
sec
macrolide antibiotics
Prior art date
Application number
LV980187A
Other languages
English (en)
Other versions
LV12211B (lv
Inventor
James V Heck
William J Leanza
Ronald W Ratcliffe
Thomas N Salzmann
Robert R Wilkening
Michael J Szymonifka
Kothandarman Shankaran
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/855,242 external-priority patent/US5985844A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of LV12211A publication Critical patent/LV12211A/lv
Publication of LV12211B publication Critical patent/LV12211B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LVP-98-187A 1991-04-04 1998-09-23 Homoeritromicīna-a atvasinājumi LV12211B (lv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68021791A 1991-04-04 1991-04-04
US81116191A 1991-12-19 1991-12-19
US07/855,242 US5985844A (en) 1992-03-26 1992-03-26 Homoerythromycin A derivatives modified at the 4"-and 8A-positions

Publications (2)

Publication Number Publication Date
LV12211A true LV12211A (lv) 1999-01-20
LV12211B LV12211B (lv) 1999-03-20

Family

ID=27418367

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-98-187A LV12211B (lv) 1991-04-04 1998-09-23 Homoeritromicīna-a atvasinājumi

Country Status (12)

Country Link
EP (1) EP0508699B1 (lv)
JP (1) JP2503156B2 (lv)
AT (1) ATE164165T1 (lv)
CA (1) CA2064634C (lv)
CY (1) CY2097B1 (lv)
DE (1) DE69224765T2 (lv)
DK (1) DK0508699T3 (lv)
ES (1) ES2113410T3 (lv)
GR (1) GR3026677T3 (lv)
HK (1) HK1009649A1 (lv)
IE (1) IE921076A1 (lv)
LV (1) LV12211B (lv)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064985A1 (en) * 1991-04-05 1992-10-06 Robert R. Wilkening 8a-aza-8a-homoertyhromycin cyclic lactams
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5686587A (en) * 1993-05-19 1997-11-11 Pfizer Inc. Intermediate for azithromycin
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
HRP940251B1 (en) * 1994-04-15 1998-12-31 Stjepan Mutak Process for the preparation of azithromycin dihydrochloride
US5958888A (en) * 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
AU4911097A (en) * 1996-11-15 1998-06-03 Pharmacia & Upjohn Company 1- and 2-substituted marcfortines and paraherquamides as antiparasitic agents
GB9705323D0 (en) * 1997-03-14 1997-04-30 Biochemie Sa Organic compounds
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HRP20000140A2 (en) * 1997-09-10 2000-12-31 Merck & Co Inc 8a-azalides as veterinary antimicrobial agents
GB9806029D0 (en) * 1998-03-20 1998-05-20 Merck & Co Inc 8a-Azalides as veterinary antimicrobial agents
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
WO1999019331A1 (en) * 1997-10-16 1999-04-22 Merck & Co., Inc. 8a-azalides, compositions containing such compounds and methods of treatment
US6733767B2 (en) * 1998-03-19 2004-05-11 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
FR2788524B1 (fr) * 1999-01-18 2002-04-26 Merial Sas Procede utile pour transformer la fonction 4"(s)-oh du motif cladinose d'un aza macrolide en 4"(r)-nh2
US6353096B1 (en) 1999-04-01 2002-03-05 Merial Process of use in converting the 4″(S)-OH functional group of the cladinose unit of an azamacrolide to 4″(R)-NH2
FR2791680B1 (fr) * 1999-03-29 2001-06-29 Merial Sas Procede utile pour reduire les intermediaires imidates issus d'un rearrangement de beckmann d'un macrocycle 8a-azalide
HUP0201516A3 (en) 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
US6590084B2 (en) 1999-12-20 2003-07-08 Merial Process for preparing and isolating 9-deoxo-9 (Z)-hydroxyiminoerythromycin A
FR2802534B1 (fr) * 1999-12-20 2002-02-01 Merial Sas Procede pour preparer et isoler la 9-deoxo-9 (z)- hydroxyiminoerythromycine a
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
FR2806724B1 (fr) * 2000-03-24 2003-12-05 Merial Sas Procede pour la preparation de derives 9-deoxo-8a-aza- (8a-alkyl)-8a-homoerythromycine a a partir de la 9-deoxo-9 (z)-hydroxyiminoerythromycine a
FR2809728B1 (fr) * 2000-05-30 2003-02-28 Merial Sas Procede utile pour transformer la fonction carbonyle en position 4" du motif cladinose d'un aza macrolide en un derive amine
US6562953B2 (en) 2000-05-30 2003-05-13 Merial Process which is useful for converting the carbonyl function in position 4″ of the cladinose unit of an aza-macrolide into an amine derivative
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
RU2263117C2 (ru) 2001-04-27 2005-10-27 Пфайзер Продактс Инк. Способ получения 4"-замещенных производных 9-деоксо-9а-аза-9а-гомоэритромицина а
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
JP2008540504A (ja) * 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用な４’’アミノ結合マクロライド
WO2006120541A1 (en) 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
EP2358732B1 (en) * 2008-10-24 2013-06-19 Merial Ltd. Method of synthesizing macrolide compounds
CN112521617B (zh) * 2020-05-21 2022-05-10 南阳师范学院 一种可用于吸附抗生素的多酸基金属有机框架材料及其制备方法和用途
CN113332238A (zh) * 2021-06-09 2021-09-03 四川恒通动保生物科技有限公司 一种加米霉素的复合溶液剂的制备方法
MX2024002892A (es) * 2021-09-07 2024-04-05 Zoetis Services Llc Azalidos inmunomoduladores.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
YU149889A (en) * 1989-07-26 1991-02-28 Pliva Zagreb Process for preparing biologically active derivatives of tylozine
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje

Also Published As

Publication number Publication date
JP2503156B2 (ja) 1996-06-05
DE69224765D1 (de) 1998-04-23
CA2064634C (en) 1998-08-04
ES2113410T3 (es) 1998-05-01
JPH05255375A (ja) 1993-10-05
GR3026677T3 (en) 1998-07-31
DE69224765T2 (de) 1998-10-15
EP0508699A1 (en) 1992-10-14
CA2064634A1 (en) 1992-10-05
ATE164165T1 (de) 1998-04-15
CY2097B1 (en) 2002-04-05
HK1009649A1 (en) 1999-06-04
EP0508699B1 (en) 1998-03-18
IE921076A1 (en) 1992-10-07
DK0508699T3 (da) 1998-05-04
LV12211B (lv) 1999-03-20

Similar Documents

Publication Publication Date Title
LV12211A (lv) Homoeritromicina-a atvasinajumi
AUPR213700A0 (en) Antiviral agents
HN1998000074A (es) Derivados de macrolidos c-4 sustituidos
RU2004109815A (ru) Пирролопиримидины в качестве средств ингибирования цистеинпротеаз
FI924226A0 (fi) Nya furyl- och tienylsubstituerade taxaner och farmaceutiska kompositioner innehaollande dessa.
NO159017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,3,4-tetrahydroisokinolin-3-karboksylsyre-derivater.
ATE327748T1 (de) Alkandiol derivate zur behandlung von knochenkrankheiten
DK0984019T3 (da) C11-carbamater fra antibakterielle macrolider
DK0992509T3 (da) Nye makrolid-derivater
ATE286031T1 (de) Substituierte 5-benzyl-2,4-diaminopyrimidine
DE69320895D1 (de) Antibiotische Carbapenemverbindungen
NZ229347A (en) Substituted cephalosporin derivatives; pharmaceutical compositions, preparatory processes and intermediates
FI910303A0 (fi) Derivat av tiazolidin med blodtrycksnedsaenkande effekt och terapeutisk anvaendning av dessa.
ATE9584T1 (de) Antibakterielle beta-lactam-verbindungen, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE69327380D1 (de) Antibiotische Pyrrolidinylthiopenemderivate
NO872982L (no) Nye tetracykliske indolderivater.
EP0802179A4 (en) DERIVATE SUBSTITUTED AMIDINONAPHTHYLESTER